Improving human health everywhere.

Science without fear.

ISV Computational Vaccinology Pre-Conference Workshop
Saturday, October 26, 2019
Ghent, Belgium

Press Release: Chugai Renews License to EpiVax’s ISPRI

In Silico Toolkit for Immunogenicity Assessment

Amsterdam Immunogenicity and Tolerance Seminar
Friday, November 15, 2019
Amsterdam, Netherlands

We are dedicated to applying our tools (in-silico, in-vitro and in-vivo) to re-engineering therapeutic proteins and to designing new vaccines. Discover

We take pride in our ability to put our combined intelligence, experience, and creativity to work to improve human health. Open minds, creative thought and natural curiosity lead to paradigm shifts. Contact us today to learn more.

Corporate Office/Laboratory:
EpiVax, Inc.

188 Valley Street, Suite 424, Providence, RI 02909 USA
ph: 401.272.2123 fax: 401.272.7562